Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer The

Email:?sorrento@factorypr.com Sorrento? and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.
G-MAB?, COVI-GUARD?, COVI-SHIELD?, COVIDTRAP?, T-VIVA-19?, COVI-MAB?, ACE-MAB?, COVI-TRACK?, Saving-Life? and Improving-Life? are trademarks of Sorrento Therapeutics, Inc. ZTlido? is a trademark owned by Scilex Pharmaceuticals Inc.
All other trademarks are the property of their respective owners.?
? 2020 Sorrento Therapeutics, Inc. All Rights Reserved. SOURCE Sorrento Therapeutics, Inc.